Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Birth Control Clinical Trials

A listing of Birth Control medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (17) clinical trials

The Effects of the Female Hormones on Cerebral Perfusion

Measuring brain perfusion is biased by a inter- and intrasubject variability, caused by physiological and lifestyle factors. In this study, the investigators want to investigate the variations in cerebral perfusion and other brain parameters (grey matter, resting-state brain activity, brain connectivity and white matter diffusion) caused by the female sex ...

Phase N/A

Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17 -estradiol (1.5mg)

NOMAC-E2 is a novel monophasic oral contraceptive containing a fixed dose of nomegestrol acetate (2.5mg) and 17-estradiol (1.5mg) which is taken for 24 days followed by 4 days of placebo. The most relevant adverse clinical outcome that has been linked to the use of COCs is venous thromboembolism (VTE). Data ...

Phase N/A

Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception

Background Hormonal contraception is widely used among women worldwide; 50-89% of all women in the Western countries use oral contraception at some point in their lives. Oral contraceptives (OC) suppress the hypothalamic-pituitary-ovarian axis through a negative feedback of ethinyl estradiol and progestins and thereby potentially influence the markers of ovarian ...

Phase N/A

Perspectives on Prescribing Hormonal Contraception Among Rural New Mexicans

There are no studies examining New Mexico pharmacists' interest in prescribing hormonal contraceptives or rural New Mexican women's support for pharmacist prescribed hormonal contraceptives. However, some states where pharmacists already prescribe contraception have experienced difficulties in implementing the education, infrastructure, and financial support necessary to provide hormonal contraception in the ...

Phase N/A

Contraceptive/HIV Affecting Risk in Adolescents

This study will evaluate the impact of hormonal contraceptives on HIV risk associated with changes to the innate immunity in the female genital tract in a cross-sectional study. HIV risk will be evaluated by the capacity of cervical tissue to replicate HIV when challenged ex vivo and correlated to the ...

Phase N/A

Improving Contraceptive Care for Women With Medical Conditions

This pilot study seeks to: To understand women's beliefs, attitudes, and experiences with contraception in context of their medical conditions, drug therapy, personal preferences, and current experiences in primary care. To describe provider- To describe provider- and practice-level factors that impact the delivery of contraceptive services in primary care. To ...

Phase N/A

Quick Start of Highly Effective Contraception

Women seeking emergency contraception (EC) frequently report multiple recent episodes of unprotected sex. Although high sensitivity urine pregnancy tests effectively rule-out pregnancy resulting from sex that occurred more than 14 days ago, clinicians are frequently concerned that pregnancy may result from unprotected sex that occurred <14 days prior to IUD ...

Phase N/A

Evaluation of Hormonal Contraceptive Treatments in Obese Women

Open, multi-center pharmacological study of residual concentrations of three different oral contraceptives in 3 groups of obese women in each group of surgery, and 1 group of healthy volunteers. The concentrations will be assessed before, 6 and 12 months after bariatric surgery restrictive (sleeve gastrectomy) or malabsorptive (gastric by pass). ...

Phase N/A

The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant

The Investigators will enroll only women with an etonogestrel contraceptive implant in place who are initiating isotretinoin therapy through their dermatologist. The Investigators will monitor the subjects serum etonogestrel concentration during isotretinoin therapy but no medications will be provided through this study. No medical devices will be inserted as part ...

Phase N/A

Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics

Approximately 350 reproductive age women (18-45) with an Etonogestrel (ENG) contraceptive implant in place for more than 1 year will be enrolled. Participants will undergo a blood draw for measurement of ENG concentration (serum) and genotyping (whole blood) and complete a questionnaire regarding their demographics and contraceptive, gynecological, and obstetrical ...

Phase N/A